A nerve pathway reduced bone loss in stressed mice
Experiments in male mice examined how prolonged stress affects marrow fat cells and how pulsed electromagnetic exposure changes bone loss through local nerve signaling. Changes in neuropeptide Y formed a central part of the response. These findings identify a mechanism for further testing, not an established osteoporosis treatment for people. Human outcomes and fracture risk remain untested.
Science··Morning
Stress changed cells in the marrow
Male mice underwent an unpredictable mild-stress regimen while bone production was measured. Neuropeptide Y released by sympathetic nerves increased a senescence-like state in marrow fat cells. The team linked that cellular shift with reduced formation of new bone tissue. The experiments focused on local communication among nerves and fat cells around bone, rather than treating all bodily effects of stress as one measurement. This connection complicates an explanation based solely on a direct response by bone cells.[1]
The pulse response depended on a nerve pathway
Pulsed electromagnetic exposure reduced stress-related bone loss in ordinary mice within the same experimental system. Mice lacking neuropeptide Y in sympathetic neurons did not show the same additional response. The missing additional response points to a role for that signaling pathway. The researchers propose that semaphorin 3A from sensory nerves acts between exposure and reduced neuropeptide Y release near marrow. Co-culture experiments and blockade of the proposed intermediate tested separate parts of that mechanism.[1]
Fewer human fractures have not been shown
The mouse response also depended on Y1R signaling in fat cells and working sensory nerves. The experiments therefore identify several testable steps in communication among bone, nerves and marrow fat cells. But the evidence comes from a constructed stress model in male mice. A suitable exposure schedule, safety and the operation of the same pathway in people remain unestablished. Improved bone measurements in mice do not demonstrate fewer fractures in humans. The result defines a mechanism for future tests rather than a clinical treatment effect.[1]
